INVO Fertility Operating Expenses Growth & History (IVF)
INVO Fertility's operating expenses was $14.1M for fiscal 2025.
View full INVO Fertility company overviewINVO Fertility annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $14.1M | $918,893 | +6.98% |
| 2024 | 2024-12-31 | $13.2M | $3.4M | +34.45% |
| 2023 | 2023-12-31 | $9.8M | −$1.7M | −14.51% |
| 2022 | 2022-12-31 | $11.4M | $2.2M | +24.02% |
| 2021 | 2021-12-31 | $9.2M | $2.8M | +42.83% |
| 2020 | 2020-12-31 | $6.5M | $3.3M | +106.59% |
| 2019 | 2019-12-31 | $3.1M | $90,567 | +2.98% |
| 2018 | 2018-12-31 | $3.0M | $2.2M | +248.96% |
| 2017 | 2017-12-31 | $870,612 | −$1.3M | −59.44% |
| 2016 | 2016-12-31 | $2.1M | $1.5M | +258.33% |
| 2015 | 2015-12-31 | $598,953 | −$1.1M | −64.55% |
| 2014 | 2014-12-31 | $1.7M | $1.1M | +171.75% |
| 2013 | 2013-12-31 | $621,712 | $33,916 | +5.77% |
| 2012 | 2012-12-31 | $587,796 | −$168,921 | −22.32% |
| 2011 | 2011-12-31 | $756,717 | — | — |
INVO Fertility quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.5M | −$1.4M | −28.61% |
| Q1 2026 | 2026-03-31 | $3.6M | $769,483 | +27.13% |
| Q4 2025 | 2025-12-31 | $3.0M | −$656,754 | −17.98% |
| Q3 2025 | 2025-09-30 | $3.4M | $659,025 | +24.11% |
| Q2 2025 | 2025-06-30 | $4.9M | $1.2M | +31.56% |
| Q1 2025 | 2025-03-31 | $2.8M | −$247,610 | −8.03% |
| Q4 2024 | 2024-12-31 | $3.7M | $762,105 | +26.37% |
| Q3 2024 | 2024-09-30 | $2.7M | $872,369 | +46.87% |
| Q2 2024 | 2024-06-30 | $3.7M | $1.3M | +54.90% |
| Q1 2024 | 2024-03-31 | $3.1M | $429,878 | +16.19% |
| Q4 2023 | 2023-12-31 | $2.9M | −$171,185 | −5.59% |
| Q3 2023 | 2023-09-30 | $1.9M | −$899,555 | −32.58% |
| Q2 2023 | 2023-06-30 | $2.4M | −$446,077 | −15.77% |
| Q1 2023 | 2023-03-31 | $2.7M | −$144,130 | −5.15% |
| Q4 2022 | 2022-12-31 | $3.1M | $564,009 | +22.58% |
| Q3 2022 | 2022-09-30 | $2.8M | $288,557 | +11.67% |
| Q2 2022 | 2022-06-30 | $2.8M | $747,518 | +35.93% |
| Q1 2022 | 2022-03-31 | $2.8M | $617,005 | +28.28% |
| Q4 2021 | 2021-12-31 | $2.5M | $523,270 | +26.51% |
| Q3 2021 | 2021-09-30 | $2.5M | $895,743 | +56.82% |
| Q2 2021 | 2021-06-30 | $2.1M | $792,609 | +61.55% |
| Q1 2021 | 2021-03-31 | $2.2M | $556,474 | +34.24% |
| Q4 2020 | 2020-12-31 | $2.0M | $933,218 | +89.65% |
| Q3 2020 | 2020-09-30 | $1.6M | $685,431 | +76.93% |
| Q2 2020 | 2020-06-30 | $1.3M | $618,677 | +92.46% |
| Q1 2020 | 2020-03-31 | $1.6M | $1.1M | +208.04% |
| Q4 2019 | 2019-12-31 | $1.0M | $416,335 | +66.66% |
| Q3 2019 | 2019-09-30 | $891,008 | $591,460 | +197.45% |
| Q2 2019 | 2019-06-30 | $669,152 | −$1.2M | −64.48% |
| Q1 2019 | 2019-03-31 | $527,565 | $297,566 | +129.38% |
| Q4 2018 | 2018-12-31 | $624,575 | $357,299 | +133.68% |
| Q3 2018 | 2018-09-30 | $299,548 | $99,857 | +50.01% |
| Q2 2018 | 2018-06-30 | $1.9M | $1.7M | +848.86% |
| Q1 2018 | 2018-03-31 | $229,999 | $24,903 | +12.14% |
| Q4 2017 | 2017-12-31 | $267,276 | −$9,443 | −3.41% |
| Q3 2017 | 2017-09-30 | $199,691 | −$19,058 | −8.71% |
| Q2 2017 | 2017-06-30 | $198,549 | −$1.3M | −86.36% |
| Q1 2017 | 2017-03-31 | $205,096 | $9,490 | +4.85% |
| Q4 2016 | 2016-12-31 | $276,719 | $41,348 | +17.57% |
| Q3 2016 | 2016-09-30 | $218,749 | $101,884 | +87.18% |
| Q2 2016 | 2016-06-30 | $1.5M | $1.3M | +1182.55% |
| Q1 2016 | 2016-03-31 | $195,606 | $62,346 | +46.79% |
| Q4 2015 | 2015-12-31 | $235,371 | −$1.1M | −81.84% |
| Q3 2015 | 2015-09-30 | $116,865 | $9,343 | +8.69% |
| Q2 2015 | 2015-06-30 | $113,457 | −$60,780 | −34.88% |
| Q1 2015 | 2015-03-31 | $133,260 | $21,739 | +19.49% |
| Q4 2014 | 2014-12-31 | $1.3M | $1.1M | +769.78% |
| Q3 2014 | 2014-09-30 | $107,522 | −$16,054 | −12.99% |
| Q2 2014 | 2014-06-30 | $174,237 | $22,381 | +14.74% |
| Q1 2014 | 2014-03-31 | $111,521 | −$85,733 | −43.46% |
| Q4 2013 | 2013-12-31 | $149,026 | $17,671 | +13.45% |
| Q3 2013 | 2013-09-30 | $123,576 | −$38,384 | −23.70% |
| Q2 2013 | 2013-06-30 | $151,856 | −$15,754 | −9.40% |
| Q1 2013 | 2013-03-31 | $197,254 | $70,383 | +55.48% |
| Q4 2012 | 2012-12-31 | $131,355 | — | — |
| Q3 2012 | 2012-09-30 | $161,960 | −$20,146 | −11.06% |
| Q2 2012 | 2012-06-30 | $167,610 | −$52,410 | −23.82% |
| Q1 2012 | 2012-03-31 | $126,871 | — | — |
| Q3 2011 · Sep 30 | 2011-09-30 | $182,106 | −$181,165 | −49.87% |
| Q2 2011 · Jun 30 | 2011-06-30 | $220,020 | −$97,578 | −30.72% |
| Q3 2011 · Sep 30 | 2010-09-30 | $363,271 | — | — |
| Q2 2011 · Jun 30 | 2010-06-30 | $317,598 | — | — |
INVO Fertility operating expenses trends
Over the last five fiscal years, INVO Fertility's operating expenses increased from $6.5M to $14.1M, a change of $7.6M. The latest reported quarter, Q2 2026, shows $3.5M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review INVO Fertility source filings ↗